Background: Diarrheal disease is a global public health problem. In Nepal, diarrhea is still the leading cause of waterborne disease, which constitutes 48% among all hospitalized disease cases who come to health center for treatment. Despite low treatment cost of diarrhea, out-of-pocket expenditure required at the time of treatment is a major barrier to seek health care. This study, therefore, aims to explore household expenditure for the diarrheal treatment in under five children and its financial burden in households.
Methods: A community based cross sectional study was carried out in 14 wards of Godawari Municipality among under five children with diarrhea from June 2018 to September 2018. We conducted financial burden survey among 371 household with diarrhea cases.
Results: Prevalence rate of diarrhea was found 50% among under five children. The average out-of-pocket expenditure was NRs 568.62 (US $5.06) per episode for diarrhea treatment. The total average direct cost for diarrheal treatment was NRs 183.58 (US $1.63). The two major cost driver during each episode were loss of wage by parents NRs 360.97 (US $3.21) and medicine costs NRs 114.15 (US $1.01).
Conclusions: The Diarrheal prevalence rate in the study area was found higher than the National. The indirect cost of each diarrheal episode is more than three times of the direct cost.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.33314/jnhrc.v17i3.2181 | DOI Listing |
BMJ Public Health
July 2024
Nutrition International, Ottawa, Ontario, Canada.
Introduction: Micronutrient deficiencies are common among women of reproductive age (WRA) and children in Senegal. Large-scale food fortification (LSFF) can help fill gaps in dietary intakes.
Methods: We used household food consumption data to model the contributions of existing LSFF programs (vitamin A-fortified refined oil and iron and folic acid-fortified wheat flour) and the potential contributions of expanding these programs to meeting the micronutrient requirements of WRA (15-49 years) and children (6-59 months).
BMJ Open
January 2025
Health Economics and Health Technology assessment, School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Objectives: To identify, measure and value the economic burden of musculoskeletal (MSK) disorders in the Kilimanjaro region, Tanzania.
Design: Community-based cross-sectional survey (undertaken between January and September 2021).
Setting: Hai district, Kilimanjaro, Tanzania.
Psychol Methods
January 2025
Department of Statistics and Data Science, Southern Methodist University.
Compositional data are multivariate data made up of components that sum to a fixed value. Often the data are presented as proportions of a whole, where the value of each component is constrained to be between 0 and 1 and the sum of the components is 1. There are many applications in psychology and other disciplines that yield compositional data sets including Morris water maze experiments, psychological well-being scores, analysis of daily physical activity times, and components of household expenditures.
View Article and Find Full Text PDFCancer
January 2025
Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania, USA.
Background: Little is known about the role that charitable copay assistance (CPA) plays in addressing access to care and financial distress. The study sought to evaluate financial distress and experience with CPA among patients with cancer and autoimmune disease.
Methods: This is a national cross-sectional self-administered anonymous electronic survey conducted among recipients of CPA to cover the costs of a drug for cancer or autoimmune disease.
Lancet Reg Health Southeast Asia
January 2025
Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Background: Treatment delays are significantly associated with advanced stage, poor response to treatment, increased mortality risk, poor health outcomes, increased healthcare expenditures among cancer patients. However, factors associated with these delays have not yet been robustly evaluated. In order to bridge this gap, we determined the delayed time to treatment initiation (TTI) among cancer patients in India, ascertained its determinants, and assessed the trends of delayed TTI.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!